Evolva launches valencene
7 December 2015 – Evolva (SIX: EVE) announces the launch of valencene, a highly prized orange flavour and fragrance (F&F) ingredient. As an alternative to extracting it from the skin of oranges, Evolva’s process allows valencene to be made in large amounts in a highly reproducible, contaminant free, sustainable and affordable manner. Evolva has developed a cost efficient manufacturing process at large production scale for valencene and we will start shipping initial commercial samples to prospective clients in January.
“Valencene is a great addition to our growing product portfolio, nicely complementing the nootkatone franchise” Evolva CEO Neil Goldsmith said. “It is also a good example of our business strategy, focusing on products with supply chain issues. As we concentrate on our core pathways, we are generating substantial synergies in terms of R&D, production as well as marketing.”
Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com. Questions about our fermentation approach? Have a look at our video.
Valencene is an orange flavour and fragrance ingredient used in food and beverage, personal care and household products, as well as an intermediate to produce nootkatone. Traditional methods of producing valencene require its extraction from the peel of oranges, meaning cost, supply and quality fluctuate depending on the harvest. Furthermore, the process is inefficient as it takes over 1 million kilograms of oranges to obtain 1 kilogram of valencene. Commercial enquiries: email@example.com.
+ 41 61 485 2005
|Jakob Dynnes Hansen
+ 41 61 485 2034
+ 41 61 485 2035
This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.
Stay informed Join our mailing list to receive Evolva’s press releases via e-mail.Join